The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 48
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte STUART A. LIPTON
__________
Appeal No. 2001-1905
Application No. 08/245,827
__________
ON BRIEF1
__________
Before ADAMS, MILLS, and GREEN, Administrative Patent Judges.
ADAMS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 11 and 13-15, which are all the claims
pending in the application.
Claim 11 is illustrative of the subject matter on appeal and is reproduced
below:
11. A method for treating a human patient to limit NMDA receptor-
mediated injury to CNS neurons by providing a pharmacologically
acceptable composition comprising glutathione and administering
said composition to said patient in an amount sufficient to limit said
neuronal injury.
1 Pursuant to appellant’s request (Paper No. 44, received July 6, 1999) an oral hearing for this
appeal was scheduled for February 21, 2002. However, we note appellant waived (Paper No. 47,
received January 15, 2002) the request for oral hearing. Accordingly, we considered this appeal
on Brief.
Page: 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007